Akèy › Maladi fwa steatotik › Florid
Etid klinik pou Maladi fwa steatotik nan Florid
20 etid pou Maladi fwa steatotik ap chèche patisipan nan sit nan Florid.
Vil nan Florid
- Miami16 etid
- Orlando9 etid
- Hialeah9 etid
- Ocala8 etid
- Cape Coral6 etid
- Sarasota6 etid
- West Palm Beach5 etid
- Jacksonville5 etid
- Brandon4 etid
- Doral4 etid
- Spring Hill4 etid
- Homestead4 etid
- The Villages3 etid
- Boca Raton3 etid
- Deltona3 etid
- St. Petersburg3 etid
- Gainesville3 etid
- Kendall3 etid
- Town 'n' Country3 etid
- Lakeland3 etid
- Melbourne3 etid
Tèks ofisyèl etid la (Anglè)
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Ocala
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Ocala
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT07701993A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Health Awareness, Inc, Jupiter
- Evolution Clinical Trials, Miami
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07527910Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- University of Miami Health System, Miami
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT05832229A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Evolution Clinical Trials, Hialeah Gardens
- Health Awareness, inc., Jupiter
- Genoma Research Group, Inc., Miami
- ak 2 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- K2 Medical Research WINTER GARDEN, Clermont
- K2 Medical Research - Daytona Beach, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- ak 20 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Bradenton
- Akero Clinical Study Site, Brandon
- Akero Clinical Study Site, Cutler Bay
- ak 23 plis
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06528314A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Boynton Beach
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Clermont
- ak 19 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT07221188A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Synergy Healthcare, Bradenton
- Synergy Healthcare, Bradenton
- Health Awareness, Inc., Jupiter
- ak 6 plis
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 9, 2026 · NCT07288138A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Brandon
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- ak 15 plis
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Clermont
- 89bio Clinical Study Site, Fort Myers
- 89bio Clinical Study Site, Gainesville
- ak 15 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT06419374Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis
- AdventHealth Translational Research Institute, Orlando
Ap rekriteVolontè an sante akeyi
Laj 25 a 55 · Tout sèks · Mizajou Aug 12, 2026 · NCT06993454A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Brandon
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami Lakes
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Aug 3, 2026 · NCT06613698A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Boynton Beach
- GSK Investigational Site, Cape Coral
- GSK Investigational Site, Clermont
- ak 20 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Jul 27, 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Miami
- GSK Investigational Site, Viera
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jul 8, 2026 · NCT06920043A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- GSK Investigational Site, Tampa
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Jun 9, 2026 · NCT07358546A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Genoma Research Group, Inc, Miami
- Med Research of Florida, LLC, Miami
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Apr 16, 2026 · NCT05648214Evaluation of Non-Invasive Tests for Metabolic Liver Disease
- Clinical Pharmacology of Miami, Miami
Ap rekriteEtid obsèvasyon
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2025 · NCT07122700Low-Dose Pioglitazone in Patients With NASH (AIM 2)
- University of Florida, Gainesville
Ap rekriteFaz 2
Laj 21 a 75 · Tout sèks · Mizajou Apr 4, 2025 · NCT04501406AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- AdventHealth Translational Research Institute, Orlando
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2025 · NCT04807868Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.